Fierce Pharma publishes a yearly special report highlighting the top 20 pharmas based on their revenue. The most recent edition, published this month, ranks each pharma based on their total revenues for 2023.
This week on "The Top Line," Fierce Pharma Senior Editor Eric Sagonowsky and Senior Writer Kevin Dunleavy break down the numbers, highlight key trends and share some of the biggest changes at the top and bottom of the rankings year over year.
To learn more about the topics in this episode:
See omnystudio.com/listener for privacy information.
Fierce Biotech's Fierce 15, plus a deep dive into drug commercialization strategies
[SPONSORED] Accelerate and Optimize Rare Disease Patient-Finding with AI
August 18, 2023
August 11, 2023
August 4, 2023
July 28, 2023
July 21, 2023
July 14, 2023
[Sponsored] Clinical trial technologies support recruitment efforts
July 7, 2023
June 30, 2023
June 23, 2023
June 16, 2023
June 9, 2023
[Sponsored] Addressing the patient centricity challenge with ZS Associates
June 2, 2023
May 26, 2023
May 19, 2023
May 12, 2023
[Sponsored] Inside Abbott’s beating heart of electrophysiology innovation
Create your
podcast in
minutes
It is Free
Pharmacy Podcast Network
Børsen Morgenbriefing
Sarah Westall - Business Game Changers
Startitup podcasty
Wall Street Breakfast